CANCER IS THE ULTIMATE ENGINEERING CHALLENGE Trademark

Trademark Overview

On Friday, August 14, 2015, a trademark application was filed for CANCER IS THE ULTIMATE ENGINEERING CHALLENGE with the United States Patent and Trademark Office. The USPTO has given the CANCER IS THE ULTIMATE ENGINEERING CHALLENGE trademark a serial number of 86725362. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 15, 2018. This trademark is owned by MERRIMACK PHARMACEUTICALS, INC.. The CANCER IS THE ULTIMATE ENGINEERING CHALLENGE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the diagnosis and treatment of cancer, oncological disorders, autoimmune disorders, inflammatory disorders, hematological disorders and dermatological disorders
cancer is the ultimate engineering challenge

General Information

Serial Number86725362
Word MarkCANCER IS THE ULTIMATE ENGINEERING CHALLENGE
Filing DateFriday, August 14, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 15, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2016

Trademark Statements

Goods and Servicespharmaceutical preparations for the diagnosis and treatment of cancer, oncological disorders, autoimmune disorders, inflammatory disorders, hematological disorders and dermatological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERRIMACK PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMERRIMACK PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, October 15, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 15, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 2, 2018EXTENSION 4 GRANTED
Friday, March 2, 2018EXTENSION 4 FILED
Friday, March 2, 2018TEAS EXTENSION RECEIVED
Saturday, September 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 7, 2017EXTENSION 3 GRANTED
Thursday, September 7, 2017EXTENSION 3 FILED
Thursday, September 7, 2017TEAS EXTENSION RECEIVED
Thursday, March 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2017EXTENSION 2 GRANTED
Tuesday, February 28, 2017EXTENSION 2 FILED
Tuesday, February 28, 2017TEAS EXTENSION RECEIVED
Friday, September 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2016EXTENSION 1 GRANTED
Wednesday, September 7, 2016EXTENSION 1 FILED
Wednesday, September 7, 2016TEAS EXTENSION RECEIVED
Friday, June 10, 2016CORRECTED NOA E-MAILED
Thursday, June 9, 2016DIVISIONAL PROCESSING COMPLETE
Monday, April 25, 2016DIVISIONAL REQUEST RECEIVED
Saturday, June 4, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 25, 2016TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, March 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2016PUBLISHED FOR OPPOSITION
Thursday, December 24, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 30, 2015ASSIGNED TO EXAMINER
Wednesday, August 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 18, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

challenge engineering ultimate cancer disorders autoimmune inflammatory hematological dermatological oncological preparations diagnosis treatment